Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Animal research suggests benefits of low-dose estrogen therapy

11.10.2004


Research in monkeys found that low-dose estrogen therapy significantly reduced the progression of fatty buildup in the arteries leading to the heart, according to research at Wake Forest University Baptist Medical Center, reported today at the annual meeting of the North American Menopause Society in Washington, D.C.

"We’ve shown that you can get the same reduction in coronary artery atherosclerosis with standard-dose or low-dose estrogen," said Thomas B. Clarkson, D.V.M., one of the investigators. "It is very significant."

The findings mirror a recent study in women, said Clarkson and Susan E. Appt, D.V.M., principal investigators of the animal study. Pharmaceutical companies are already marketing lower doses of the drug.



The monkey study looked at whether 0.3 milligrams per day of oral conjugated equine estrogen (CEE) would be as effective at reducing progression of atherosclerosis as the traditional oral dose of 0.625 milligrams per day (found in Premarin). Two groups of postmenopausal monkeys were fed a moderately fatty diet for 10 months – similar to the typical human diet – to induce the buildup of fat deposits in the arteries. For two years, the monkeys were then given the human equivalent of low-dose CEE or no estrogen.

Evaluation of the three main arteries leading to the heart showed that monkeys that were treated with estrogen had 55 percent less atherosclerosis than the monkeys that didn’t receive estrogen. This is similar to the results previously obtained in monkeys who received the traditional dose of estrogen.

The monkeys were selected to be equivalent to women during the early postmenopausal years. "This study suggests that low-dose estrogen may be as effective at inhibiting atherosclerosis as the traditional dose in early postmenopausal subjects," said Clarkson, professor of comparative medicine.

Clarkson said the findings are important because they suggest that women who are taking low-dose estrogen for their menopausal symptoms may also benefit from a heart disease perspective. Several studies are evaluating the low-dose therapy in women.

A recent study by Kwang Kon Koh at Hokkaido University Graduate School of Medicine in Japan, compared women who received low-dose and standard-dose estrogen – in combination with the hormone progestin – for two months. The researchers found that the two doses had comparable favorable effects on several markers of cardiovascular health, including cholesterol concentrations and artery flexibility. In addition, the lower doses were less likely to result in changes that increase the risk of blot clot formation, which can lead to heart attacks and stroke.

The Kronos Longevity Research Institute is funding a five-year study of women ages 45 to 54. The study will recruit 900 women to evaluate an oral tablet containing low-dose estrogen, a skin patch delivering estrogen or a placebo. At the end of the five years, researchers will use ultrasound to evaluate the thickness of artery walls. Thickened artery walls are a sign of early atherosclerosis.

Also involved in the Wake Forest Baptist research was Mary Anthony, Ph.D., who was at Wake Forest Baptist at the time the research took place.

Karen Richardson | EurekAlert!
Further information:
http://www.wfubmc.edu

More articles from Life Sciences:

nachricht Designer cells: artificial enzyme can activate a gene switch
22.05.2018 | Universität Basel

nachricht Flow of cerebrospinal fluid regulates neural stem cell division
22.05.2018 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: LZH showcases laser material processing of tomorrow at the LASYS 2018

At the LASYS 2018, from June 5th to 7th, the Laser Zentrum Hannover e.V. (LZH) will be showcasing processes for the laser material processing of tomorrow in hall 4 at stand 4E75. With blown bomb shells the LZH will present first results of a research project on civil security.

At this year's LASYS, the LZH will exhibit light-based processes such as cutting, welding, ablation and structuring as well as additive manufacturing for...

Im Focus: Self-illuminating pixels for a new display generation

There are videos on the internet that can make one marvel at technology. For example, a smartphone is casually bent around the arm or a thin-film display is rolled in all directions and with almost every diameter. From the user's point of view, this looks fantastic. From a professional point of view, however, the question arises: Is that already possible?

At Display Week 2018, scientists from the Fraunhofer Institute for Applied Polymer Research IAP will be demonstrating today’s technological possibilities and...

Im Focus: Explanation for puzzling quantum oscillations has been found

So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics

Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...

Im Focus: Dozens of binaries from Milky Way's globular clusters could be detectable by LISA

Next-generation gravitational wave detector in space will complement LIGO on Earth

The historic first detection of gravitational waves from colliding black holes far outside our galaxy opened a new window to understanding the universe. A...

Im Focus: Entangled atoms shine in unison

A team led by Austrian experimental physicist Rainer Blatt has succeeded in characterizing the quantum entanglement of two spatially separated atoms by observing their light emission. This fundamental demonstration could lead to the development of highly sensitive optical gradiometers for the precise measurement of the gravitational field or the earth's magnetic field.

The age of quantum technology has long been heralded. Decades of research into the quantum world have led to the development of methods that make it possible...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Save the date: Forum European Neuroscience – 07-11 July 2018 in Berlin, Germany

02.05.2018 | Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

 
Latest News

Designer cells: artificial enzyme can activate a gene switch

22.05.2018 | Life Sciences

PR of MCC: Carbon removal from atmosphere unavoidable for 1.5 degree target

22.05.2018 | Earth Sciences

Achema 2018: New camera system monitors distillation and helps save energy

22.05.2018 | Trade Fair News

VideoLinks
Science & Research
Overview of more VideoLinks >>>